Dianne Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dianne Miller has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ashleen Shadeo
Cancer Genetics & Developmental Biology, British Columbia Cancer Research Centre, Vancouver, BC, Canada
1 shared publication - Calum MacAulay
Basic and Translational Research, BC Cancer Research Institute, 675 West 10th Avenue, Vancouver, BC V5Z Il3, Canada
1 shared publication - Dirk van Niekerk
Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
1 shared publication - Greg Vatcher
Cancer Genetics & Developmental Biology, British Columbia Cancer Research Centre, Vancouver, BC, Canada
1 shared publication - Jasenka Matisic
Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
1 shared publication - Jennifer Campbell
Cancer Genetics & Developmental Biology, British Columbia Cancer Research Centre, Vancouver, BC, Canada
1 shared publication
Latest Publications
- Open Access
- 1 January 2007
- Published by Springer Nature in BMC Genomics
- Vol. 8 (1) , 142
Comprehensive serial analysis of gene expression of the cervical transcriptome
More than half of the approximately 500,000 women diagnosed with cervical cancer worldwide each year will die from this disease. Investigation of genes expressed in precancer lesions compared to those expressed in normal cervical epithelium will yield insight into the early stages of disease. As such, establishing a baseline from which to compare to, is critical in elucidating the abnormal biology of disease. In this study we examine the normal cervical tissue transcriptome and investigate the similarities and differences in relation to CIN III by Long-SAGE (L-SAGE). We have sequenced 691,390 tags from four L-SAGE libraries increasing the existing gene expression data on cervical tissue by 20 fold. One-hundred and eighteen unique tags were highly expressed in normal cervical tissue and 107 of them mapped to unique genes, most belong to the ribosomal, calcium-binding and keratinizing gene families. We assessed these genes for aberrant expression in CIN III and five genes showed altered expression. In addition, we have identified twelve unique HPV 16 SAGE tags in the CIN III libraries absent in the normal libraries. Establishing a baseline of gene expression in normal cervical tissue is key for identifying changes in cancer. We demonstrate the utility of this baseline data by identifying genes with aberrant expression in CIN III when compared to normal tissue.
- 1 January 2007
- Published by Springer Nature in BMC Genomics
- Vol. 8 (1) , 142
Open AccessComprehensive serial analysis of gene expression of the cervical transcriptome
More than half of the approximately 500,000 women diagnosed with cervical cancer worldwide each year will die from this disease. Investigation of genes expressed in precancer lesions compared to those expressed in normal cervical epithelium will yield insight into the early stages of disease. As such, establishing a baseline from which to compare to, is critical in elucidating the abnormal biology of disease. In this study we examine the normal cervical tissue transcriptome and investigate the similarities and differences in relation to CIN III by Long-SAGE (L-SAGE). We have sequenced 691,390 tags from four L-SAGE libraries increasing the existing gene expression data on cervical tissue by 20 fold. One-hundred and eighteen unique tags were highly expressed in normal cervical tissue and 107 of them mapped to unique genes, most belong to the ribosomal, calcium-binding and keratinizing gene families. We assessed these genes for aberrant expression in CIN III and five genes showed altered expression. In addition, we have identified twelve unique HPV 16 SAGE tags in the CIN III libraries absent in the normal libraries. Establishing a baseline of gene expression in normal cervical tissue is key for identifying changes in cancer. We demonstrate the utility of this baseline data by identifying genes with aberrant expression in CIN III when compared to normal tissue.